ES
47
2
FOXA
59
2
ORLY
41
-7
SYF
83
2
SEE
53
-3
DE
40
-2
SPG
55
4
GT
38
-3
BF.B
54
-4
NDAQ
69
2
LEN
32
-4
EMN
53
3
KMI
53
-2
UNP
48
-4
DOW
40
2
AZO
38
-8
NAVI
19
-13
AIG
51
-2
PNW
60
8
STT
73
2
ES
47
2
FOXA
59
2
ORLY
41
-7
SYF
83
2
SEE
53
-3
DE
40
-2
SPG
55
4
GT
38
-3
BF.B
54
-4
NDAQ
69
2
LEN
32
-4
EMN
53
3
KMI
53
-2
UNP
48
-4
DOW
40
2
AZO
38
-8
NAVI
19
-13
AIG
51
-2
PNW
60
8
STT
73
2
Financhill
Back

UiPath, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
53

PATH
UiPath, Inc.

Last Price:
$18.67
Seasonality Move:
-14.79%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$89.98
Seasonality Move:
7.7%
Buy
53
UiPath, Inc. (PATH) is a Buy

Is UiPath, Inc. a Buy, Sell or Hold?

  • The current UiPath, Inc. [PATH] share price is $18.98. The Score for PATH is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • PATH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

PATH Stock Price Chart

What is UiPath, Inc.'s stock price today?

  • The UiPath, Inc. share price today is $18.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PATH is experiencing selling pressure, which indicates risk of future bearish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $86.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

PATH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.97 Buy
Relative Strength Index (14 RSI): 75.14 Buy
Chaikin Money Flow: -10812586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.84 - 16.58) Buy
Bollinger Bands (100): (11.13 - 15.59) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.97 Buy
Relative Strength Index (14 RSI): 72.81 Buy
Chaikin Money Flow: -897315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.72 - 73.96) Buy
Bollinger Bands (100): (43.27 - 64.19) Buy

PATH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.57 Buy
20-day SMA: 14.81 Buy
50-day SMA: 15.17 Buy
200-day SMA: 12.66 Buy
8-day EMA: 17.14 Buy
20-day EMA: 15.69 Buy
50-day EMA: 14.79 Buy
200-day EMA: 13.5 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.38 Buy
20-day SMA: 67.89 Buy
50-day SMA: 62.54 Buy
200-day SMA: 44.51 Buy
8-day EMA: 75.59 Buy
20-day EMA: 69.41 Buy
50-day EMA: 62.91 Buy
200-day EMA: 49.79 Buy

UiPath, Inc. Earnings Growth & PATH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.01 per share, and an increase next year of $0.20 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.36 per share.

UiPath, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):